Lipocine Inc at Ladenburg Thalmann Healthcare Conference Transcript

Sep 29, 2022 / 07:00PM GMT
Unidentified Participant

My pleasure to introduce our next presenting company, Lipocine. And presenting for the company is CEO, Mahesh Patel. Thanks.

Mahesh Patel - Lipocine Inc. - Chairman, President & CEO

All right. Thanks, Matt. Good afternoon, all, and thanks for participating. I am Mahesh Patel; I'm the President, CEO and Co-Founder of Lipocine.

First, 2022 has been a transformative year for Lipocine because we got our first product approved commercialized through a partner. And that means we have validated our technology, which I'll dive into more in detail. And we are truly excited about the opportunities that we're pursuing, and the future looks bright.

As you may know, a couple of days ago, we announced our strategy realignment with regards to our development focus targeted towards treating CNS disorders. And I'll tell you why, and also about our technology that is enabling us to engage in this forward focus on the CNS assets.

So before we do that, let's go through some official business, forward-looking statements. Give it a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot